ELEVATED MIDTRIMESTER HCG AND MATERNAL LUPUS ANTICOAGULANT

Citation
F. Clark et al., ELEVATED MIDTRIMESTER HCG AND MATERNAL LUPUS ANTICOAGULANT, Prenatal diagnosis, 15(11), 1995, pp. 1035-1039
Citations number
17
Categorie Soggetti
Obsetric & Gynecology
Journal title
ISSN journal
01973851
Volume
15
Issue
11
Year of publication
1995
Pages
1035 - 1039
Database
ISI
SICI code
0197-3851(1995)15:11<1035:EMHAML>2.0.ZU;2-0
Abstract
An association is described between women with lupus anticoagulant and abnormal prenatal serum screening results. Three cases of positive se cond-trimester serum screening for Down syndrome, with karyotypically normal fetuses, in women demonstrated to have lupus anticoagulant are presented. Serum screening positivity was principally due to a disprop ortionately elevated maternal serum human chorionic gonadotrophin (hCG ) level, In each case, early, severe intrauterine growth restriction w as documented, with only one fetus surviving the neonatal period. As m aternal lupus anticoagulant may have a profoundly adverse effect on th e course of pregnancy, we suggest that an elevated hCG level on prenat al screening prompt consideration of maternal lupus anticoagulant test ing if ultrasonography demonstrates an otherwise normal singleton gest ation and the fetal karyotype is normal.